Source-grounded facts extracted from RadNet, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
RadNet, Inc. shareholders approved Approve the amendment and restatement of the Company’s Equity Incentive Plan at the 2026-06-02 meeting.
“Proposal 4 The proposal to approve the amendment and restatement of the Company’s Equity Incentive Plan disclosed in the Company’s 2026 definitive proxy statement was approved based on the following votes: For Against Abstentions Broker Non-Votes 63,254,838 1,844,622 33,746 8,119,301”
RadNet, Inc. shareholders approved Non-binding advisory vote to approve the compensation of Named Executive Officers at the 2026-06-02 meeting.
“Proposal 3 The non-binding advisory vote to approve the compensation of the Company’s Named Executive Officers disclosed in the Company’s 2026 definitive proxy statement was approved based on the following votes: For Against Abstentions Broker Non-Votes 61,158,497 3,892,047 82,662 8,119,301”
RadNet, Inc. shareholders approved Ratify the appointment of Ernst & Young LLP as independent registered public accounting firm for year ending December 31, 2026 at the 2026-06-02 meeting.
“Proposal 2 The proposal to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was approved based on the following votes: For Against Abstentions 72,890,772 346,990 14,745”
RadNet, Inc. shareholders approved Election of six directors to hold office until the 2027 Annual Meeting at the 2026-06-02 meeting.
“Proposal 1 The stockholders elected the following six directors to hold office until the 2027 Annual Meeting of Stockholders or until their successors are duly elected and qualified based on the following votes:”
RadNet, Inc. reported the first quarter ended March 31, 2026 results: revenue $575.6 million, EPS $(0.28). Guidance raised.
“Financial Results and Revises Upwards 2026 Imaging Center Financial Guidance Ranges for Revenue, Adjusted EBITDA and Free Cash Flow · Total Company Revenue increased 22.1% to $575.6 million in the first quarter of 2026 from $471.4 million in the first quarter of 2025 · Revenue from the Digital Health reportable segment increased 51.5% to $29.1 million in the first”
RadNet, Inc. incurred term loan of $100.0 million with Barclays Bank PLC maturing April 18, 2031.
“Pursuant to the Second Amendment, Barclays Bank PLC, as lender, agreed to provide the Borrower an Incremental Term Commitment (as defined by the Existing Credit Agreement) in an aggregate principal amount of $100.0 million (the "2025 Incremental Term Loan"), which will be added to and form a part of the existing term loan under the Existing Credit Agreement (the "Existing Term Loan," together with the 2025 Incremental Term Loan, the "Term Loan").”
Cornelis "Kees" Wesdorp was appointed as President and Chief Executive Officer of its Digital Health segment at RadNet, Inc..
“On September 11, 2024 RadNet, Inc. (“RadNet”) appointed Cornelis “Kees” Wesdorp, age 47, to serve as President and Chief Executive Officer of its Digital Health segment (“Digital Health”), which includes RadNet’s eRad and Artificial Intelligence businesses, effective October 1, 2024.”
RadNet, Inc. updated its first quarter ended March 31, 2024 guidance (raised).
“On May 8, 2024 RadNet, Inc. (“RadNet”) issued a press release and, on May 9, 2024, held a conference call regarding its 2024 financial results for the first quarter ended March 31, 2024.”
RadNet, Inc. reported fourth quarter and full year ended December 31, 2023 results: revenue $420.4 million, EPS $0.20. Guidance raised.
“RadNet Reports Fourth Quarter 2023 Results, Including Record Revenue and Adjusted EBITDA (1) , Releases 2024 Financial Guidance and Forms a New Digital Health Reporting Segment · Revenue increased 9.5% to a record $420.4 million in the fourth quarter of 2023 from $383.9 million in the fourth quarter of 2022”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.